SGO on the GO
SGO on the GO is the Society of Gynecologic Oncology's best education for the busy clinician. Join us for discussions regarding clinical practice, advances in research, and other compelling topics relevant to gynecologic oncology.
Episodes
63 episodes
Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Trastuzumab Deruxtecan ENHERTU®)
This is the last of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trastuzumab Deruxtecan EN...
•
11:52
Part 2: Keeping up with the Chemos Series: Administration of Trastuzumab Deruxtecan ENHERTU®
This is the second of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. Our multidisciplinary panel will discuss the important information about the drug preparation and administ...
•
14:08
Part 1: Keeping up with the Chemos Series: Preparing to Give Trastuzumab Deruxtecan ENHERTU®
This is the first of the three-part podcast series, Keeping up with the Chemos on Trastuzumab Deruxtecan ENHERTU®. After going over some general information on Trastuzumab Deruxtecan ENHERTU® including when to use the drug, chec...
•
21:45
ERAS Guidelines: Same Day Discharge (SDD)
In this podcast, we will focus on same day discharge as part of Enhanced Recovery after Surgery (ERAS).Over the past two decades, and especially after the publication of the GOG LAP2 trial, minimally invasive surgery has been wid...
•
13:27
Immunotherapy Part 3: Common Controversies and Remaining Questions
This episode is part 3 of the Immunotherapy podcast series, which continues discussion of common controversies affecting the use of immune checkpoint inhibitors (ICIs) in the clinic, such as optimal dosing strategies, influence of toxicity on r...
•
17:57
Immunotherapy Part 2: Common Controversies
This episode is part 2 of the Immunotherapy Series, which reviews common controversies affecting daily use of immune checkpoint inhibitors (ICIs) in the clinic, such as treatment options for immune related adverse effects beyond corticos...
•
22:47
Part 3: Updates and Highlights from Summer NRG Oncology 2023
Join Dr. Robert Neff as he interviews Drs. Kathleen Moore and Charles Leath, III to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between SGO members and NRG O...
•
33:32
Locally Advanced Cervical Cancer: Discussion of Radiation Techniques & Management
Episode three of the Radiation Therapy podcast series discusses radiation techniques and management with regard to locally advanced cervical cancer. Host/Moderator: Leigh A. Cantrell, MD, MSPHProfessor, Dep...
•
15:11
Diversity and Inclusion in Clinical Trials
Join Dr. Janelle Darby, member of the SGO Clinical Trials Management/Concepts Subcommittee, as she interviews Drs. Evan Graboyes, Jeffrey Hines, and Bhavana Pothuri, addressing continued efforts to improve inclusion of racially and ethnically d...
•
21:44
ERAS Guidelines: Surgical Site Infection Reduction Bundle (SSI Bundle)
This podcast focuses on the surgical site infection reduction bundle as part of the ERAS guidelines that was first published in 2016 and updated in 2019, and the 2020 vulvar and vaginal surgeries ERAS guidelines.Before we dive into the ...
•
17:22
Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Trabectedin and Doxorubicin)
This is the last of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trabectedin and Doxorubicin. ...
•
14:01
Part 2: Keeping up with the Chemos Series: Administration of Trabectedin and Doxorubicin
This is the second of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of ...
•
13:38
Part 1: Keeping up with the Chemos Series: Preparing to Give Trabectedin and Doxorubicin
This is the first of the three-part podcast series, Keeping up with the Chemos on Trabectedin and Doxorubicin. After going over some general information on Trabectedin and Doxorubicin including when to use the drug, checking pat...
•
15:16
Applied Radiation: A Deep Dive in Therapeutics for Gyn Malignancies
Episode two of the Radiation Therapy podcast series discusses treatment of Oligometastatic disease, re-irradiation and role of palliative radiation, utilization of SBRT, introduction to proton therapy and mitigation of radiation-associ...
•
31:18
Immunotherapy Part 1: Basics of Immune-Related Adverse Events
This episode is part 1 of the Immunotherapy podcast series, which reviews immune-checkpoint inhibitors encountered in the gynecologic oncology setting, common immunotherapy toxicities and patient counseling on them, as well as the basi...
•
23:19
Radiation Therapy: Introduction to Principles & Applications in Gynecologic Malignancies
This episode is part 1 of the Radiation Therapy podcast series, which looks to review and address the basic fundamentals of radiation therapy in the gynecologic oncology setting. Host: Mian M. Shahzad, MD PhD (Gynecologi...
•
22:04
Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Trametinib)
This is the last of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Trametinib. When to dose adjust and hold or ev...
•
16:11
Part 2: Keeping up with the Chemos Series: Administration of Trametinib
This is the second of the three-part podcast series, Keeping up with the Chemos on Trametinib. Our multidisciplinary panel will discuss the important information about the drug preparation and administration of Trametinib. Focus...
•
7:11
Part 1: Keeping up with the Chemos Series: Preparing to Give Trametinib
This is the first of the three-part podcast series, Keeping up with the Chemos on Trametinib. After going over some general information on Trametinib including mutation status considerations, baseline lab testing, ocular toxicit...
•
11:25
Episode 24: (Part 3) Key Concepts of Enhanced Recovery After Surgery. ERAS – How Well Do We Do It?
The goal of this podcast is to continue our series on key concepts of enhanced recovery after surgery (ERAS). In September 2022, the SGO Education Committee's ERAS Subcommittee discussed why we do it, and in February 2023, we talked about how w...
•
17:07
Ways to Wellness Podcast Series, Episode 1: It’s 3am, Do You Know Where Your Fellows Are?
Let’s face it, wellness is an ever-evolving concept. Listen in as we celebrate aspects of wellness throughout the SGO community. These are 10–20-minute quarterly snippets to highlight the authentic voices from SGO and beyond. Stay connected and...
•
Season 1
•
Episode 1
•
33:34
Part 2: Updates and Highlights from Winter NRG Oncology 2023
Join Dr. Kathryn Mills as she interviews Drs. Jubilee Brown, Ann Klopp, Joyce Liu, and Jyoti Mayadev to discuss the latest NRG Oncology updates on upcoming studies, research, and trials. The focus for the podcast is to bridge the gaps between S...
•
43:03
Part 3: Keeping up with the Chemos Series: Follow up Monitoring Between Cycles (Mirvetuximab soravtansine)
This is the last of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. Our multidisciplinary panel will discuss the challenges with patient monitoring while on Mirvetuximab soravtansine...
•
11:14
Part 2: Keeping up with the Chemos Series: Administration of Mirvetuximab soravtansine
This is the second of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. Our multidisciplinary panel will discuss the important information about creating chemotherapy orders, the drug prepar...
•
9:58
Part 1: Keeping up with the Chemos Series: Preparing to Give Mirvetuximab soravtansine
This is the first of the three-part podcast series, Keeping up with the Chemos on Mirvetuximab soravtansine. After going over some general information on Mirvetuximab soravtansine including mechanism of action and indication. Th...
•
13:20